Evidence map›Paper›PMID 42100135›Full record

ArticleFrontiers in pain research (Lausanne, Switzerland)2026

Sex, gender, and sociodemographic factors associated with repeated prescription refills in chronic pain: insights from a prescription claims cohort study.

Marimée Godbout-Parent, Nancy Julien, Hermine Lore Nguena Nguefack, M Gabrielle Pagé, Line Guénette, Lucie Blais, Nancy Ménard, Sylvie Beaudoin, Anaïs Lacasse

Abstract read
In one paragraph

Article in Frontiers in pain research (Lausanne, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Marimée Godbout-ParentDépartement des Sciences de la Santé, Université du Québec en Abitibi-Témiscamingue (UQAT), Rouyn-Noranda, QC, Canada.
Nancy JulienDépartement des Sciences de la Santé, Université du Québec en Abitibi-Témiscamingue (UQAT), Rouyn-Noranda, QC, Canada.
Hermine Lore Nguena NguefackDépartement des Sciences de la Santé, Université du Québec en Abitibi-Témiscamingue (UQAT), Rouyn-Noranda, QC, Canada.
M Gabrielle PagéCentre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM), Montréal, QC, Canada.
Line GuénetteFaculté de Pharmacie, Université Laval, Québec, QC, Canada.
Lucie BlaisFaculté de Pharmacie, Université de Montréal, Montréal, QC, Canada.
Nancy MénardChaire de recherche institutionnelle en épidémiologie de la douleur chronique, Rouyn-Noranda, QC, Canada.
Sylvie BeaudoinChaire de recherche institutionnelle en épidémiologie de la douleur chronique, Rouyn-Noranda, QC, Canada.
Anaïs LacasseDépartement des Sciences de la Santé, Université du Québec en Abitibi-Témiscamingue (UQAT), Rouyn-Noranda, QC, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: Chronic pain (CP) disproportionately affects women and gender-diverse individuals, raising questions about how sociodemographic factors influence medication use. Yet, the interplay between sex, gender, and prescribed medication use in CP remains poorly understood, limiting optimization, safety, and equity of care. We examined how sex and gender are associated with repeated prescription refills of pain medications among individuals with CP. Methods: This study was conducted among individuals living with CP and links self-reported data to public and private prescription claims ( Results: Most commonly used medications prescribed for CP and related comorbidities were antidepressants (48%), anticonvulsants (35%), opioids (19%), and nonsteroidal anti-inflammatory drugs (18%) (repeated refills). Between clusters, statistically significant differences were found for the subgroups labelled: (1) 'W Conclusion: Our results highlight how sex, gender, and intersecting sociodemographic factors are associated with repeated prescription refills, particularly opioids and antidepressants, among individuals living with CP.

Indexed as

antidepresantschronic paingendermedicationopioidspharmacological treatmentsexSGBA+

Identifiers

PMID42100135
PMCPMC13143939

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.